Chemical sympathectomy further increases muscle protein degradation of acutely diabetic rats

Muscle and Nerve

Volumn 38, Issue 2, 2008, Pages 1027-1035

  Baviera, Amanda Martins ^a   Zanon, Neusa Maria ^a   Navegantes, Luiz Carlos C ^a   Migliorini, Renato Hélios ^a   Kettelhut, Isis C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Catecholamines; Chemical sympathectomy; Diabetes; Muscle protein metabolism; Proteolytic pathways

Indexed keywords

CATECHOLAMINE; GUANETHIDINE; MUSCLE PROTEIN; NORADRENALIN; PROTEASOME; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHRL1;

ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CHEMICAL SYMPATHECTOMY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXTENSOR DIGITORUM LONGUS MUSCLE; MALE; MUSCLE LEVEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SOLEUS MUSCLE; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CALCIUM; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; EPINEPHRINE; FORKHEAD TRANSCRIPTION FACTORS; GUANETHIDINE; LYSOSOMES; MALE; MUSCLE PROTEINS; MUSCLE, SKELETAL; NOREPINEPHRINE; ONCOGENE PROTEIN V-AKT; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, WISTAR; SYMPATHECTOMY, CHEMICAL; TIME FACTORS; UBIQUITIN;

EID: 49449097930     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21018     Document Type: Article

References (33)

1. Adeghate E, Parvez H. The effect of diabetes mellitus on the morphology and physiology of monoamine oxidase in the pancreas. Neurotoxicology 2004;25:167-173.
2. Adeghate E, Ponery AS, Sheen R. Streptozotocin-induced diabetes mellitus is associated with increased pancreatic tissue levels of noradrenaline and adrenaline in the rat. Pancreas 2001;22:311-316.
3. 2+-dependent and ATP-proteasome-dependent proteolysis in skeletal muscle from acutely diabetic rats. Am J Physiol Endocrinol Metab 2007;286:E702-E708.
4. Fushimi H, Inoue T, Namikawa H, Kishino B, Nishikawa M, Tochino Y, et al. Increased norepinephrine content in diabetic rat heart. J Bioehem 1982;91:1805-1807.
5. Garófalo MA, Kettelhut IC, Roselino JE, Migliorini, RH. Effect of acute cold exposure on norepinephrine turnover rates in rat white adipose tissue. J Auton Nerv Syst 1996;60:206-208.
6. Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Bioehem Cell Biol 2005;37:1974-1984.
7. Guttridge DC. Signaling pathways weigh in on decisions to make or break skeletal muscle. Curr Opin Clin Nutr Metab Care 2004;7:443-450.
8. Hasselgren PO. Glucocorticoids and muscle catabolism. Curr Opin Clin Nutr Metab Care 1999;2:201-205.
9. Hoover F, Mathiesen I, Skalhegg BS, Lomo T, Tasken K. Differential expression and regulation of the PKA signaling pathway in fast and slow skeletal muscle. Anat Embryol 2001;203:193-201.
10. Jackman RW, Kandarian, SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 2004;287:C834-C843.
11. Jensen J, Brennesvik EO, Bergersen H, Oseland H, Jebens E, Brors O. Quantitative determination of cell surface β-adrenoceptors in different rat skeletal muscles. Pflugers Arch Eur J Physiol 2002;444:213-219.
12. Kadowaki M, Kamata T, Noguchi T. Acute effect of epinephrine on muscle proteolysis in perfused rat hindquarters. Am J Physiol Endocrinol Metab 1996;270:E961-E967.
13. Kline WO, Panaro FJ, Yang H, Bodine SC. Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol. J Appl Physiol 2007;102:740-747.
14. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
15. 2+-dependent and ubiquitin-proteasome-dependent proteolytic pathways in fast-twitch and slow-twitch rat muscle following hyperinsulinaemia. Clin Sci 2001;101:551-558.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
17. Mitch WE, Medina R, Grieber S, May RC, England BK, Price SR, et al. Metabolic acidosis stimulates muscle protein degradation by activating the ATP-dependent pathway involving ubiquitin and proteasomes. J Clin Invest 1994;93:2127-2133.
18. Navegantes LC, Migliorini RH, Kettelhut IC. Adrenergic control of protein metabolism in skeletal muscle. Curr Opin Clin Nutr Metab Care 2002;5:281-286.
19. 3-adrenergic agonist, inhibits protein breakdown in rat skeletal muscle. Pflugers Arch Eur J Physiol 2006;451:617-624.
20. Navegantes LC, Resano NM, Migliorini RH, Kettelhut IC. Effect of guanethidine-induced adrenergic blockade on the different proteolytic systems in rat skeletal muscle. Am J Physiol Endocrinol Metab 1999;277:E883-E889.
21. Navegantes LC, Resano NM, Migliorini RH, Kettelhut IC. Role of adrenoceptors and cAMP on the catecholamine-induced inhibition of proteolysis in rat skeletal muscle. Am J Physiol Endocrinol Metab 2000;279:E663-E668.
22. 2-adrenoceptors and cAMP. Am J Physiol Endocrinol Metab 2001;281:E449-E454.
23. Pepato MT, Migliorini RH, Goldberg AL, Kettelhut IC. Role of different proteolytic pathways in degradation of muscle protein from streptozotocin- diabetic rats. Am J Physiol Endocrinol Metab 1996;271:E340-E347.
24. Quansah FA, Klatt C, Feldman JM. Effects of diabetes mellitus and chemical sympathectomy on tissue monoamine oxidase activity and norepinephrine concentration in the golden hamster. Metabolism 1981;30:242-247.
25. Rosdahl H, Samuelsson AC, Ungerstedt U, Henriksson J. Influence of adrenergic agonists on the release of amino acids from rat skeletal muscle studied by microdialysis. Acta Physiol Scand 1998;163:349-360.
26. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004;117:399-412.
27. Sensky PL, Parr T, Bardsley RG, Buttery PJ. The relationship between plasma epinephrine concentration and the activity of the calpain enzyme system in porcine longissimus muscle. J Anim Sci 1996;74:380-387.
28. Shamoon H, Jacob R, Sherwin RS. Epinephrine-induced hypoaminoacidemia in normal and diabetic human subjects: effect of beta blockade. Diabetes 1980;29:875-881.
29. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, et al. The IGF-1/P13K/AKT pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting Foxo transcription factors. Mol Cell 2004;14:395-403.
30. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979;76:4350-4354.
31. Viguerie N, Clement K, Barbe P, Courtine M, Benis A, Larrouy D, et al. In vivo epinephrine-mediated regulation of gene expression in human skeletal muscle. J Clin Endocrinol Metab 2004;89:2000-2014.
32. Waalkes TP, Udenfriend S. A fluorimetric method for the estimation of tyrosine in plasma and tissues. J Lab Clin Med 1957;50:733-736.
33. Wang X, Hu Z, Hu J, Du J, Mitch WE. Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 2006;147:4160-4168.